Physician profile
Christopher Payne
NPI 1477962876
$28,434.09
in general payments reported to CMS, 2019-2025
12 companies · $681 in 2025
The $681 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $113 · 2021: $271 · 2022: $1,700 · 2023: $640 · 2024: $29.23 · 2025: $681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883 · Travel and Lodging: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $883.40 |
| Travel and Lodging | $466.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25,057.86 | 2019-2022 | |
| Si-Bone, INC. | $1,480.97 | 2021-2024 | |
| Orthofix Medical, INC. | $614.59 | 2023 | 7d Surgical System |
| Medtronic, INC. | $544.20 | 2022-2025 | N/A, Inceptiv |
| Depuy Synthes Sales INC. | $368.20 | 2021-2025 | Velys, Conduit, Zero-P |
| Spinal Simplicity, LLC | $91.30 | 2025 | Ha Minuteman G3-R |
| Aesculap, INC. | $72.12 | 2021 | |
| Abbott Laboratories | $69.30 | 2020 | |
| Stryker Corporation | $48.88 | 2021-2022 | |
| Globus Medical, INC. | $34.47 | 2025 | Hedron |
| Arteriocyte Medical Systems, INC. | $27.73 | 2022 | |
| Integra Lifesciences Corporation | $24.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Payne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.